hVIVO made 4 separate poster presentations at Options IX for the Control of Influenza in August 2016 (Chicago, USA)
Click here and complete your details to get access to these insightful hVIVO posters.
No less than four poster presentations addressing key issues such as immunity development, vaccinating older populations, differential infectivity and volunteer screening using the hVIVO platform were presented by hVIVO experts at the prestigious Options IX for the Control of Influenza event.
The hVIVO Poster Sessions, summarised here, can still be viewed by following the link below:
“The Human Viral Influenza Challenge Model: The Relationship between Infection Rates, Virus Shedding, Symptoms, Pyrexia and Pre-existing Humoral and Cellular Immunity.”Dr. Anthony Gilbert, hVIVO Medical Director
“Human influenza challenge of an older population (45 to 65 years of age).” Dr. Nicolas Noulin, hVIVO Principal Virologist
“Use of allele specific RT-qPCR to measure the differential infectivity of HA variants in human infection models using A/Wisconsin/67/2005.” Dr. Nicolas Noulin, Principal Virologist
“Influenza haemagglutination inhibition assay: improving robustness and reproducibility is important in the screening of volunteers into a Human Viral Challenge Study.” Dr. Nicolas Noulin, Principal Virologist
Click here and complete your details to get access to these insightful hVIVO posters, especially useful if you didn’t get to attend Options IX in Chicago yourself!